Study of New Implantable Loop Recorder

NCT ID: NCT00746564

Last Updated: 2019-01-30

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

75 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-09-30

Study Completion Date

2014-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this IDE clinical study is to evaluate the quality of the cardiac signal recordings obtained by the St. Jude Medical (SJM) Confirm Implantable Cardiac Monitor (device).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Tachyarrhythmias Syncope

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Open Label

SJM Confirm Device

Group Type EXPERIMENTAL

SJM Confirm

Intervention Type DEVICE

All patients in this study will receive the SJM Confirm device.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

SJM Confirm

All patients in this study will receive the SJM Confirm device.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients who have clinical syndromes or situations at increased risk of cardiac arrhythmias
* Patients who experience transient symptoms that may suggest a cardiac arrhythmia
* Patients who have been previously diagnosed with atrial fibrillation
* Patients who are suspected to have Atrial Fibrillation (AF) but AF has not been documented
* Patients who have provided written informed consent to participate in the study.

Exclusion Criteria

* Patients who are under the age of 18 years
* Patients who have a life expectancy less than 1 year
* Patients who are unable to comply with the follow-up schedule
* Patients who are currently implanted with a pacemaker or defibrillator
* Patients who the physician deems inappropriate for the study
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Abbott Medical Devices

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Tamara Shipman

Role: STUDY_DIRECTOR

Abbott Medical Devices

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Alaska Heart Institute

Anchorage, Alaska, United States

Site Status

Arizona Arrhythmia Research

Scottsdale, Arizona, United States

Site Status

Arkansas Heart Hospital

Little Rock, Arkansas, United States

Site Status

St. Jude Hospital

Fullerton, California, United States

Site Status

Scripps Clinic

La Jolla, California, United States

Site Status

Oklahoma Heart Institute at Utica

Tulsa, Oklahoma, United States

Site Status

Providence- St Vincent Medical Center

Portland, Oregon, United States

Site Status

Texas Cardiac Arrhythmia Research Foundation

Austin, Texas, United States

Site Status

University of Virginia

Charlottesville, Virginia, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

60020941D

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

3T MRI CIED Post-Approval Study
NCT02969395 COMPLETED